Sleep disordered breathing in children receiving vagus nerve stimulation therapy.

Sleep Med

Division of Pulmonary and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

Published: March 2021

AI Article Synopsis

  • * A retrospective analysis at Cincinnati Children's Hospital included 22 pediatric patients who underwent VNS therapy; findings revealed high incidences of symptoms like snoring and nighttime awakenings, with many diagnosed with obstructive sleep apnea (OSA) post-treatment.
  • * The study concluded that SDB, including OSA and hypoventilation, frequently occurs in this demographic, often requiring various management strategies such as CPAP, bilevel PAP, or surgeries, emphasizing the necessity for screening SDB among these patients. *

Article Abstract

Objective: The effects of vagus nerve stimulation (VNS) on sleep disordered breathing (SDB) have been reported in limited case series. Detailed studies, particularly in the pediatric population, have not been performed. The primary purpose of this study is to describe clinical characteristics, polysomnographic findings, and management of children treated with VNS.

Methods: A retrospective review of medical records and polysomnography data was performed in patients ages 0-20 years old receiving VNS therapy for refractory epilepsy at Cincinnati Children's Hospital Medical Center.

Results: 22 subjects met the inclusion criteria. 50% were male. The mean age at the time of VNS insertion was 8.4 ± 4.0 years. The mean age at the first PSG was 10.6 ± 4.3 years. Common presentations to sleep clinics included snoring (77.3%), frequent nighttime awakening (68.1%), and parasomnias (63.6%). The median apnea-hypopnea index (AHI) was 4.5/hr (IQR 3.0-13.1) and the median obstructive index (OI) was 4.1/hr (1.5-12.8). Obstructive sleep apnea (OSA) was diagnosed after VNS insertion in 19 patients (86.4%), 8 of which (36.3%) had severe OSA. Six patients (27.3%) had significant hypoventilation. For management, 6 patients (27.2%) were treated with bilevel PAP, 3 patients (13.6%) with CPAP, 2 patients (9.1%) with ventilator, 4 patients (18.2%) with upper airway surgeries, and 9 patients (40.9%) received medications only.

Conclusions: SDB is common in pediatric patients with medically refractory epilepsy managed with VNS who were referred to sleep medicine clinics. Both OSA and nocturnal alveolar hypoventilation are relatively common in this population. Management of SDB often involves the use of positive airway pressure therapy or upper airway surgeries. Further studies are needed to assess the prevalence, risk factors, and the effect of treatments on epilepsy control. This study highlights the need for screening of SDB prior to and following VNS implantation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sleep.2020.12.021DOI Listing

Publication Analysis

Top Keywords

patients
9
sleep disordered
8
disordered breathing
8
vagus nerve
8
nerve stimulation
8
refractory epilepsy
8
vns insertion
8
upper airway
8
airway surgeries
8
vns
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!